Interpace Biosciences, Inc. financial data

Symbol
IDXG on OTC
Location
Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % +25.2%
Quick Ratio 13.9 % +6.44%
Debt-to-equity -1.34K % -3517%
Return On Equity -353 % -3090%
Return On Assets 28.3 % -37.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.43M shares +0.54%
Common Stock, Shares, Outstanding 4.43M shares +0.54%
Entity Public Float 4M USD +5.65%
Common Stock, Value, Issued 407K USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 4.43M shares +0.73%
Weighted Average Number of Shares Outstanding, Diluted 27.7M shares +526%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 41.9M USD -6.12%
Cost of Revenue 15.9M USD -2.4%
Research and Development Expense 694K USD +9.46%
Selling and Marketing Expense 10.9M USD -4.1%
General and Administrative Expense 9.84M USD +12.2%
Operating Income (Loss) 4.57M USD -39.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.1M USD -32.7%
Income Tax Expense (Benefit) -11K USD -375%
Net Income (Loss) Attributable to Parent 3.8M USD -35.5%
Earnings Per Share, Basic 0 USD/shares -43.3%
Earnings Per Share, Diluted 0 USD/shares -156%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.42M USD +1.64%
Accounts Receivable, after Allowance for Credit Loss, Current 5.97M USD -18.2%
Inventory, Net 1.1M USD -9.51%
Other Assets, Current 1.74M USD +2.17%
Assets, Current 9.13M USD +0.33%
Property, Plant and Equipment, Net 1.54M USD +14%
Operating Lease, Right-of-Use Asset 1.32M USD -13.8%
Other Assets, Noncurrent 45K USD 0%
Assets 12M USD -14.3%
Accounts Payable, Current 1.41M USD -17%
Employee-related Liabilities, Current 1.45M USD -14.2%
Liabilities, Current 5.95M USD +0.76%
Long-term Debt and Lease Obligation 1.75M USD -41.1%
Operating Lease, Liability, Noncurrent 864K USD -27.3%
Other Liabilities, Noncurrent 5.53M USD +5.7%
Liabilities 12.3M USD -31.6%
Retained Earnings (Accumulated Deficit) -233M USD +1.6%
Stockholders' Equity Attributable to Parent -298K USD +99.4%
Liabilities and Equity 12M USD -14.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.24M USD
Net Cash Provided by (Used in) Financing Activities -1.5M USD -150%
Net Cash Provided by (Used in) Investing Activities -28K USD +56.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.57M shares +0.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -265K USD +61.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.42M USD -32.7%
Deferred Tax Assets, Valuation Allowance 35.1M USD -4.99%
Operating Lease, Liability 1.28M USD -14.1%
Payments to Acquire Property, Plant, and Equipment 28K USD -56.9%
Lessee, Operating Lease, Liability, to be Paid 1.51M USD -19.6%
Property, Plant and Equipment, Gross 4.21M USD +26.2%
Operating Lease, Liability, Current 419K USD +37.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 550K USD +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 550K USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 229K USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 275K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 24.1M USD -3.43%
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 877K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275K USD
Amortization of Intangible Assets 900K USD -30.8%
Depreciation, Depletion and Amortization 95K USD +82.7%
Deferred Tax Assets, Net of Valuation Allowance 168K USD +700%
Share-based Payment Arrangement, Expense 104K USD -70%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares